Clinical trials
Myopia trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 11 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chang Gung Memorial Hospital | 4 |
| Visco Vision Inc. | 4 |
| China Medical University Hospital | 3 |
| National Taiwan University Hospital | 3 |
| Buddhist Tzu Chi General Hospital | 2 |
| Far Eastern Memorial Hospital | 2 |
| Sunhawk Vision Biotech, Inc. | 2 |
| Yung Sheng Optical Co., Ltd. | 2 |
| ApexLens Co., Ltd. | 1 |
| China Medical University, China | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myopia | 34 |
| Refractive Errors | 3 |
| Anisometropia | 2 |
| Asthenopia | 2 |
| Astigmatism | 2 |
| Cataract | 2 |
| Myopia, Degenerative | 2 |
| Dental Caries | 1 |
| Hypersensitivity | 1 |
| Presbyopia | 1 |
Trials
Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.